Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

ACHV Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Achieve Life Sciences, Inc.NASDAQ: ACHV

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses grows, but more slowly than its trailing trend

Q1 FY2026 other income / expenses of $295K rose 340.3% year over year, behind the +357.0% change in trailing-twelve-month other income / expenses. Sequentially, it rose 327.5% from the prior quarter.

Context

  • Other income / expenses increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +340.3% toward the trailing-twelve-month pace of +357.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$295K+327.5% QoQ
Last fiscal yearDec 2025
$232K+130.6% YoY
LTMMar 2026
$460K+357.0% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+340.3%——
1 year+130.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
232K USD
Year-over-year change
+130.6%

Other Income / Expenses vs competitors

How ACHV compares with its peers on the latest reported figures

No competitor Other Income / Expenses figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000229K228K
Gross Profit000(229K)(228K)
Gross Margin—————
Research & Development23.97M30.08M15.81M22.82M22.96M
Selling, General & Admin9.13M10.72M11.44M16.25M31.87M
Operating Expenses33.09M40.8M27.25M38.84M54.65M
Depreciation & Amortization250K236K228K229K228K
EBITDA(32.9M)(40.33M)(26.73M)(37.42M)(53.6M)
EBITDA Margin—————
Operating Income(33.09M)(40.8M)(27.25M)(39.07M)(54.88M)
Operating Margin—————
Interest Income17K199K825K2.36M1.5M
Interest Expense01.79M2.85M2.18M819K
Other Income / Expenses(58K)(1.55M)(2.57M)(758K)232K
Income Before Tax(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Net Margin—————
EPS (Basic)(4.05)(3.95)(1.50)(1.24)(1.25)
EPS (Diluted)(4.05)(3.95)(1.50)(1.24)(1.25)
Weighted Avg Shares8.12M10.59M19.83M32.07M43.59M
Weighted Avg Shares (Diluted)8.12M10.59M19.83M32.07M43.59M

Achieve Life Sciences, Inc.

NASDAQ:ACHV

Intrinsic Alpha fair value

Locked

Current Price

$6.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.